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Bloodstream Infections in Late-Stage Acquired Immunodeficiency
Syndrome Patients Evaluated by a Lysis Centrifugation System
RC Rosas/*, R Salomão/*, DA da Matta, HV Lopes**, AC Pignatari, AL Colombo/+
Hospital São Paulo, Universidade Federal de São Paulo, Rua Napoleão de Barros 715, 04024-002 São Paulo, SP, Brasil
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Opportunistic infections, which affect acquired immunodeficiency syndrome (Aids) patients, are frequently dis-
seminated and may cause bloodstream infections (BSI).  The aim of this study was to evaluate the main causes of BSI
in Aids patients with advanced stage of the disease, with special emphasis on the identification of fungemia.  During
a 21 months period, all patients with Aids (CD4 < 200) and febrile syndrome admitted to 3 university hospitals were
systematically evaluated.  For each patient presenting fever, a pair of blood cultures was collected and processed by
using a commercial lysis-centrifugation system.
One hundred and eleven patients (75 males) with a mean age of 36 years (median 33 years) and mean CD4 count
of 64 cells/ml were included. Among the 111 patients evaluated we documented 54 episodes of BSI, including 46
patients with truly systemic infections and 8 episodes considered as contaminants.  BSI were caused by gram-
positive bacteria (43%), fungi (20%), gram-negative bacteria (15%), mycobacteria (15%), and mixed flora (7%).
The crude mortality rate of our patients was 39%, being 50% for patients with BSI and 31% for the others. In
conclusion, BSI are a common related to systemic infections on Aids patients with advanced stage of disease and is
associated with a high rate of mortality.
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Systemic infections on acquired immunodeficiency
syndrome (Aids) patients frequently have the concomi-
tant presence of pathogens on blood due to the failure of
the host defenses to contain an infection at the primary
focus. Aids patients present a disorder of the immune
system mainly related to functional abnormalities and
quantitative depletion of CD4+ T-lymphocytes, but it also
may include deficiency of B-lymphocytes, macrophages
and polymorphonuclear cells. This complex disorder of
the immune system leads not only to the increased sus-
ceptibility of human immunodeficiency virus (HIV)-pa-
tients to opportunistic pathogens but also to bacterial
agents (Tumbarello et al. 1995). Besides immunological
changes, the intravenous drug abuses as well as the ex-
tensive use of central venous catheters for therapeutic
proposes are factors that may corroborate to predispose
the development of bloodstream infections (BSI) in HIV-
patients. In addition, hospitalized Aids patients may also
develop bacteremia as a complication of invasive medical
procedures such as urinary catheterization and mechani-
cal ventilation (Tumbarello et al. 1995, Petrosillo et al. 2002).
There is scarce information about the pathogens related
to bloodstream infections on Aids patients admitted on
Brazilian tertiary care hospitals. We conducted a cross-
sectional study to evaluate epidemiologic characteristics
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and species distribution of pathogens related to blood-
stream infections documented on Aids patients, with spe-
cial emphasis on fungemic episodes.
PATIENTS AND METHODS
During a 21 month-period we evaluated Aids inpa-
tients at advanced stage of the disease who experimented
more than 3 days of fever at any time during the hospital-
ization at 3 tertiary care hospitals from São Paulo, Brazil:
Hospital e Maternidade Santa Marcelina, Hospital
Heliópolis and  Hospital São Paulo, Universidade Federal
de São Paulo.
We selected all patients older than 13 years old, who
had a febrile syndrome (temperature ≥ 38°C) and late stage
of Aids confirmed by HIV serology and CD4+ T lympho-
cyte count ≤ 200 cells/ml. We excluded all patients who
had the identification of the etiologic agent of the febrile
syndrome before hospitalization.  All enrolled patients
had a pair of blood cultures collected at the admission
and any time during the hospitalization if they developed
unknown origin fever after the admission. The blood cul-
tures were aseptically collected at no less than hourly
intervals. A 10 ml blood sample from each culture col-
lected was directly inoculated into isolator system vial
(Wampole Laboratories, Cranbury, New Jersey, USA) and
processed according to the manufacturer’s instructions.
In brief, the bottles were centrifuged for 30 min and
aliquots of the obtained sediment were seeded in blood
agar, chocolate agar, brain-heart infusion, Sabouraud dex-
trose agar and Löwenstein-Jensen culture media. The cul-
tures were incubated at 35°C during a period of up to 45
days.
The investigator visited the selected patients once a
week to report demographic and clinical data, as well as
all laboratory results related to the investigation of the
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febrile episode. For each patient the following informa-
tion was systematically collected: sex, age, risk factors for
HIV infection, previous opportunistic infections, signs
and symptoms of the infection, results of laboratory tests
of interest to the case, use of antimicrobial agents, pres-
ence of a central venous catheter (CVC) and outcome.
The patients were followed from the admission up to
discharge or death. It is important to note that except for
the blood cultures that were systematically collected, all
lab tests and other diagnostic procedures were only re-
quested by individual decision of the assistant physi-
cian.
The bacteria isolates were identified by means of mi-
croscopical examination as well as biochemical tests. The
mycobacteria were identified by their morphology on Ziehl-
Nielsen stain, as well as by biochemical tests (NCCLS
1995). Yeasts were identified based on their morphologi-
cal characteristics and biochemical profile evaluated by
the API 20C AUX disposable plastic galleries (BioMérieux
SA, Marcy-l’Etoille, France).  Filamentous and dimorphic
fungi were identified according to the micromorphologic
characteristics of the culture (Warren & Hazen 1995, Hoog
& Guarro 1995).
The definition of BSI was based on that proposed by
the Center of Disease Control, Atlanta, USA and it re-
quired that ≥ 1 culture of blood samples, which were ob-
tained in the presence of fever  (body temperature ≥ 38°C)
not attributable to other causes, yielded bacteria or yeast
(Garner et al. 1988). Cases in which a single blood culture
yielded coagulase-negative staphylococci, Corynebac-
terium species and Bacillus species were classified as
“pseudo-bloodstream infections” (Reimer et al. 1997, Kim
et al. 2000).
BSI were considered nosocomial if signs and symp-
toms became evident > 48 h after admission to the hospi-
tal or if the patient had been hospitalized 2 weeks before
the current admission (Garner et al. 1988). All infections
due to Mycobacterium, Cryptococcus neoformans and
Histoplasma capsulatum were considered as community
acquired infections.
RESULTS
We were able to evaluate 111 patients (68% male) with
age ranging from 20 to 76 years (mean 36 years), exhibit-
ing a CD4+ count between 1 and 200 (mean 64 cells).
Patient’s risk factors for HIV infection were as follows:
non-drug users heterosexual patients (48%), intravenous
drug users (20%), homossexuals (7%), bissexuals (3%),
and unknown risk group (22%).
Almost 70% of the population was under highly ac-
tive antiretroviral therapy (HAART) or other regimens of
antiretroviral therapy at the time they were first evaluated.
Only 14% of the patients presented, at any time during
the study, a total granulocytes count of < 1000 cells/ml.
We found that 40% of the patients had an indwelling medi-
cal device in place at the time they were sampled and 68%
of them had already been exposed to previous antibiotic
therapy. The main causes of hospitalization were: fever of
unknown origin 28%, pneumonia 25%, neurologic syn-
dromes 24%, hepatoesplenic febrile syndrome 17% and
chronic diarrhea 6%.
A total of 54 out 111 evaluated patients exhibited posi-
tive blood cultures during the study, including 46 epi-
sodes considered as truly BSI and 8 judged as contami-
nation. The distribution of pathogens related to BSI was
as follows: 43% of episodes were caused by gram-posi-
tive bacteria, 20% by fungi, 15% by gram-negative, 15%
by Mycobacterium spp. and 7% were caused for mixed
flora (Table). The rate of BSI in our population was 41%,
including 17 (37%) episodes of community-acquired and
29 (63%) of nosocomial-acquired infections.
The most common etiological agents of BSI were: Sta-
phylococcus aureus (41%), M. tuberculosis (13%), P.
mirabilis, C. neoformans, H. capsulatum and C. albicans
(7% each), P. aeruginosa (4%), coagulase-negative sta-
phylococci, A. baumanii, S. marcescens and M. avium
complex (2% each), and mixed flora episodes (6%).
The following agents represented community-ac-
quired BSI: M. tuberculosis (7 episodes), S. aureus (4), C.
neoformans (3), and H. capsulatum (3). Hospital-acquired
BSI was represented by: S. aureus (15), C. albicans (3), P.
mirabilis (3), P. aeruginosa (2), A. baumanii, coagulase-
negative staphylococci and S. marcescens (1 each) and
mixed flora infections (3).
Gram-positive bacteria were the etiologic agent respon-
sible for 20 episodes of BSI, mostly represented by S.
aureus hospital-acquired infections. It is noteworthy that
53% of them had a CVC in place at the time they were
sampled and 66% of them were drug users. Patients with
BSI for staphylococci exhibited CD4 + T lymphocyte count
< 50 cells/ml in 66% of cases and a normal number of
granulocytes.
Gram-negative bacteria were responsible for 7 episodes
of hospital-acquired BSIs and P. mirabilis was the patho-
gen most commonly isolated. Gram-negative infections
TABLE
Organisms isolated from acquire immunodeficiency syndrome
patients with bloodstream infections, 1997-1999
Microorganism Nr of patients %
Gram (+) 20 43
   Staphylococcus aureus 19
   Coagulase-negative Staphylococcus 1
Fungi 9 20
   Yeasts 6
      Crytococcus neoformans 3
      Candida albicans 3
   Dimorphic 3
      Histoplasma capsulatum 3
Gram (-) 7 15
   Proteus mirabilis 3
   Pseudomonas aeruginosa 2
    Acinetobacter baumanii 1
   Serratia marcescens 1
Mycobacteria 7 15
   Mycobacterium tuberculosis 6
   Mycobacterium avium complex 1
Polymicrobial 3 7
Total 46 100
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were mostly documented in patients who developed noso-
comial pneumonia (57%). Patients with BSI for Gram-nega-
tive bacteria presented CD4+ T lymphocyte count < 50
cells/ml in 57% of cases and a normal number of granulo-
cytes.
C. albicans was responsible for 3 episodes of noso-
comial acquired BSI and were documented in patients with
more than 14 days of hospitalization and a CVC in place
(100%) at the time they were sampled. Regarding labora-
tory tests, patients with candidemia presented CD4+ T
lymphocyte count < 100 cells/ml and a normal number of
granulocytes.
Cryptococcemia (3 cases) was documented in patients
with a history of prolonged fever related to meningeal
and/or pneumonic syndromes.  Regarding to laboratory
tests we should emphasize that all them had a normal num-
ber of granulocytes and CD4+ T lymphocyte count < 50
cells/ml.
H. capsulatum bloodstream infections (3 cases) were
documented in patients with prolonged fever, hepatosple-
nomegaly and CD4+ T lymphocyte count < 50 cells/ml.
Mycobacterium spp. infections were found in 7 pa-
tients (15%) with a predominance of M. tuberculosis (6).
Mycobacteremia was documented in patients with pro-
longed fever and hepatoesplenomegaly syndrome. Re-
garding laboratory tests, no patient presented granulo-
cytopenia, and all them had CD4+ T lymphocyte count <
50 cells/ml.
The crude mortality rate of our patients was 39%, be-
ing 50% for patients with BSI and 31% for the others.
Mortality rates of infections due to different pathogens
were as follows: gram-negative bacteria (43%), gram-posi-
tive bacteria (45%), fungi (55.5%) and Mycobacterium
spp. (86%). Mortality rates were 45% for hospital-acquired
and 59% for community-acquired bloodstream infections.
DISCUSSION
In the present study we evaluated the prevalence of
BSI in Aids patients with advanced stage of disease ad-
mitted to the hospital without diagnosis of the ongoing
infection.
The main epidemiological characteristics of the Aids
population included in this study was similar to that ex-
hibited by most HIV patients in Brazil. We had a gender
distribution of men 2:1 women and heterosexual transmis-
sion as the major risk factor for HIV infection.
We were able to identify 46 episodes (41%) of blood-
stream infections in 111 patients. S. aureus was the patho-
gen most commonly associated with BSI in this study,
responding for 41% of all episodes. Despite some authors
have postulated that coagulase-negative staphylococci
is the major agent of bacteremia in Aids patients, other
investigators have found S. aureus as the predominant
agent of BSI among gram-positive bacteremic episodes
(Whimbey et al. 1986, Jacobson et al. 1988, Schaberg et al.
1991, Banerjee et al. 1991, Emori & Gaynes 1993, Goetz et
al. 1994). The ample presence of patients with a history of
intravenous drug use in our population may, in part, ex-
plain the predominance of  S. aureus among the BSI. The
use intravenous drugs as well as S. aureus nasal carries
are both factors that had been recognized as risk factors
for S. aureus bacteremia among Aids patients (Tuazon &
Sheagren 1974, Ganesh et al. 1989, Raviglione et al. 1990).
Infections with gram-negative bacteria, the third cause of
BSI in our patients, were related to pneumonia and neuro-
logical syndromes with reduced consciousness and ne-
cessity of mechanical ventilation.  The etiologies of gram-
negative BSI showed a predominance of Proteus mirabilis
and Pseudomonas aeruginosa, pathogens commonly as-
sociated with nosocomial pneumonia in Brazilian institu-
tions (Sader et al. 2001). Regarding laboratory tests, this
patient population presented CD4+ T lymphocyte counts
< 50 cells/ml (70%) and absence of neutropenia with the
supposedly primary infectious focus being nosocomial
pneumonia.  Gram-negative BSI in Aids patients have been
commonly associated with diarrhea, including agents as
Salmonella sp. and Shiguella sp. (Tumbarello et al. 1995,
Salavert Lleti et al. 1996). The difference between our find-
ings and the literature may be related with the diversity of
Aids patients evaluated on different series. It is notewor-
thy that we excluded outpatients of this study and evalu-
ated exclusively late-stage Aids patients who required
hospitalization.
The infections with Mycobacterium spp. occurred in
patients with prolonged fever, hepatosplenomegaly and
disseminated lymphadenomegaly and all of them pre-
sented CD4+ T lymphocyte counts < 100 cells/ml.  These
findings are similar to those reported in other series, par-
ticularly in Latin America, where infections with Myco-
bacterium represent a significant public health problem.
It should be pointed out that 6 of 7 Mycobacterium spp.
were M. tuberculosis, confirming the higher prevalence
of these species in causing opportunistic infections in
patients with Aids in Brazil (Grynsztejn et al. 1997).
Of the many Aids-associated infections, the invasive
fungal infections are relatively common, especially in pa-
tients with a CD4+ T lymphocyte count of less than 200
cells/ml.  Yeasts of the Candida and Cryptococcus gen-
era are the most frequently identified fungi as cause of
infection in these patients (Mess & Daar 1997).  In our
patients, fungemia corresponded to 20% of the episodes
of infection, with the following distribution: C.
neoformans, H. capsulatum and C. albicans.
As expected, C. neoformans and H. capsulatum rep-
resented the majority of the documented episodes of
fungemia in our series. Otherwise, we observed a high
incidence of patients with candidemia, a complication re-
ported in 7% of our cases. It should be mentioned that all
these patients presented a long period of hospitalization
and multiple risk factors for candidemia, including the pres-
ence of CVC, use of long-term parenteral alimentation,
antibiotics, mucosal Candida infection and surgical pro-
cedures. These findings confirm previous observations
in patients with HIV infection, where candidemia appears
related to patients with advanced HIV disease and mul-
tiple risk factors for candidemia including invasive medi-
cal procedures, antibiotic use, as well as Candida coloni-
zation (Launay et al. 1998, Tumbarello et al. 1999).
After reviewing the English literature, we found 4 stud-
ies evaluating BSI in Aids patients (Whimbey et al. 1986,
Hickey & Shanson 1993, Meyer et al. 1994, Tumbarello et
al. 1995) using different blood culture methods (BACTEC
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NR6A, COLORBACT, radiometric BACTEC 460), show-
ing a variation of 35% to 73.4% in the proportion of BSI
with gram-positive bacteria, 23.4% to 32.9% with gram-
negative and 0.6 to 4.8% in candidemia.  We did not find
any study using systematically the isolator system in the
investigation of systemic infections in patients with Aids.
Data on BSI due to Candida sp. (7%) obtained in our
series were higher than those mentioned before, but
equivalent to the rate found in a study with systematic
evaluation of infections by necropsy (10%) (Wilkes et al.
1988).  It is possible that the difference between the indi-
ces we found for candidemia and the previously published
data is due to the fact that our evaluated patients were in
worst clinical status and also to the better performance of
the isolator in recognizing fungemia.
The design of the present study did not allow an ac-
curate analysis of the isolator’s performance related to
other diagnostic methods.  However, we may say that the
isolator system contributed to the diagnosis of 41% of all
episodes evaluated, including infections difficult to be
diagnosis as candidemia, histoplasmosis and mycobac-
teremia. In conclusion BSI is a common complication of
Aids patients with advanced stage of disease and is re-
lated with a high rate of mortality. Blood cultures per-
formed by lysis-centrifugation method may be a useful
tool for the diagnostic of opportunistic infections in Aids
patients at advanced stage of disease.
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